Hot Stock: Hansen Medical, Shares Drop 5.2% (HNSN)
Comtex SmarTrend(R) - Wed Dec 24, 10:34AM CST
Hansen Medical (NASDAQ:HNSN) is one of today's worst performing penny stocks, down 5.2% to $0.54 on 1.1x average daily volume. Thus far today, Hansen Medical has traded 383,000 shares, vs. average volume of 351,000 shares per day. The stock has underperformed the Dow (-5.2% to the Dow's 0.3%) and underperformed the S&P 500 (-5.2% to the S&P's 0.2%) during today's trading.
HNSN: 0.55 (-0.02)
Hot Stock: Hansen Medical, Shares Gain 6.6% (HNSN)
Comtex SmarTrend(R) - Fri Dec 19, 10:09AM CST
Hansen Medical (NASDAQ:HNSN) is one of today's best performing penny stocks, up 6.6% to $0.63 on 2.7x average daily volume. Thus far today, Hansen Medical has traded 749,000 shares, vs. average volume of 279,000 shares per day. The stock has outperformed the Dow (5.9% to the Dow's 0.2%) and outperformed the S&P 500 (5.9% to the S&P's 0.3%) during today's trading.
HNSN: 0.55 (-0.02)
Hansen Medical Announces Key Developments in Global Expansion Strategy
Marketwired - Fri Dec 19, 7:55AM CST
Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, today announced key recent developments in the company's global expansion strategy. Hansen and AB Medica s.p.a today announced an exclusive distribution agreement for Magellan(TM) and Sensei(R) Robotic Systems in Italy. In addition, the company's exclusive distribution partner in Kingdom of Saudi Arabia and United Arab Emirates, AFYA Medical Group, completed the first end user hospital installation of a Magellan system in the Middle East, at King Fahd Hospital in Jeddah, Saudi Arabia, in October.
HNSN: 0.55 (-0.02)
Global Medical Robotics Market 2014-2020: Surgical Robot, Rehabilitation Robotics, Telemedicine, Assistive Robots, Orthotics, Prosthetics, Radio Surgery, Exoskeleton
M2 - Fri Dec 12, 2:53AM CST
Research and Markets (http://www.researchandmarkets.com/research/vg63ft/global_medical) has announced the addition of the "Global Medical Robotics Market by Application, Type - Segmentation and Forecast 2014-2020" report to their offering. Advances in healthcare technology over the years have showed tremendous growth. From surgical devices to radio imaging and treatment methods, all aspects of medicines have taken technological leaps in the recent decades, making healthcare technology one of the most lucrative markets. The demand for robotics in healthcare, especially surgical procedures is increasing. Robotic procedures are deemed safer in situations where humans might make errors, as robotic procedures have far greater precision and leave minimum margin for error, and therefore having robotic systems in a hospital would be able to generate more revenue. Robots can also create better clinical outcomes and curtail labour costs, leading to an exponential growth in demand. However, surgery is not the only field with robotic advancements. Robotic panels are found in all segments of healthcare, such as sanitation and for disinfecting purposes, sterilization of instruments, processing laboratory supplies and other fields where technology aids and can replace human effort. Robotics in medicine is viewed as an all-round technological advancement, which is not limited to only one section. This is potentially the biggest leap in technology for the healthcare industry since the introduction of IT and has the scope of commercially being a vibrant industry with extensive chains of supply, production and R&D development. This technology, however, is limited to economies that are invested in medical care to a great extent. For instance, the possibility of investment into robotic arms to enhance surgical procedure in public hospitals in a developing country such as Ghana is unlikely but the developed economies of North America and Europe are the most lucrative markets for medical robotics as they have significantly invested in healthcare. However; Asian countries such as India and China are the markets of the future as the governments of these coutries are putting in efforts to improve healthcare and the economies will show a significant growth. Key Topics Covered: 1. Executive summery 2. Healthcare robotics market overview 3. Market determinants 4. Market segmentation 5. Cost analysis 6. Market strategies 7. Market share 8. Geography analysis 9. Corporate profiles - Titan Medical Inc - Siemens Healthcare - Robotic Surgical Tech, Inc. - Medtronic, Inc. - Hitachi Medical Corp. - Hansen Medical, Inc - Ge Healthcare - Immersion Corp. - Mako Surgical Corp - Mazor Robotics Ltd For more information visit http://www.researchandmarkets.com/research/vg...al_medical
MDT: 74.08 (+0.31), HNSN: 0.55 (-0.02), IMMR: 9.45 (+0.47), MZOR: 13.01 (-0.68)
Stock to Watch: Hansen Medical Down 6.5% (HNSN)
Comtex SmarTrend(R) - Thu Dec 04, 12:40PM CST
Hansen Medical (NASDAQ:HNSN) is one of today's worst performing penny stocks, down 6.5% to $0.69 on 1.6x average daily volume. Thus far today, Hansen Medical has traded 349,000 shares, vs. average volume of 217,000 shares per day. The stock has underperformed the Dow (-6.2% to the Dow's 0.0%) and underperformed the S&P 500 (-6.2% to the S&P's 0.0%) during today's trading.
HNSN: 0.55 (-0.02)
Insider Trading Alert - HNSN, K And FLEX Traded By Insiders
at The Street - Thu Dec 04, 11:29AM CST
Stocks with insider trader activity include HNSN, K and FLEX
FLEX: 11.25 (+0.11), HNSN: 0.55 (-0.02), K: 67.02 (-0.22)
Hansen Medical Announces Completion of First Robotic Prostatic Artery Embolization Procedure (PAE) in the United States
Marketwired - Thu Nov 20, 6:01AM CST
Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, today announced the completion of the first robotic prostatic artery embolization (PAE) in the United States. Dr. Sandeep Bagla, interventional radiologist, performed the procedure at Inova Alexandria Hospital in Alexandria, Virginia using the Magellan(TM) Robotic System.
HNSN: 0.55 (-0.02)
Hansen Medical to Highlight New Magellan(TM) 6Fr Robotic Catheter at 41st Annual VEITHsymposium(R)
Marketwired - Wed Nov 19, 3:07PM CST
Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, today announced it will exhibit its Magellan(TM) Robotic System at the 41st Annual VEITHsymposium(R) November 18 - 22 at the New York Hilton-Midtown in New York City. The Company will be conducting product demonstrations of the new Magellan 6Fr Robotic Catheter and exhibiting the Magellan Robotic System to Vascular Surgeons and Interventionalists at its exhibit booth (#416).
HNSN: 0.55 (-0.02)
Hansen Medical posts 3Q loss
Automated Insights - Fri Nov 07, 4:48AM CST
MOUNTAIN VIEW, Calif. (AP) _ Hansen Medical Inc. (HNSN) on Friday reported a loss of $15.6 million, or 13 cents per share, in its third quarter.
HNSN: 0.55 (-0.02)
Hansen Medical misses by $0.03, misses on revenue
Seeking Alpha - at Seeking Alpha - Thu Nov 06, 4:12PM CST
HNSN: 0.55 (-0.02)
Hansen Medical Reports Third Quarter 2014 Operating Results and Recent Business Highlights
Marketwired - Thu Nov 06, 3:26PM CST
Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, today reported recent business highlights and financial results for the third quarter of fiscal year 2014 ended September 30, 2014.
HNSN: 0.55 (-0.02)
Notable earnings after Thursday’s close
Seeking Alpha - at Seeking Alpha - Wed Nov 05, 4:35PM CST
BEBE: 2.48 (-0.15), ACET: 21.85 (-0.07), ANET: 65.00 (+0.30), FNGN: 37.85 (+0.79), CPST: 0.74 (+0.01), AUQ: 3.08 (+0.10), AMRN: 0.99 (unch), ED: 66.91 (+0.90), ENV: 51.94 (+1.62), FXCM: 16.88 (-0.12), BCEI: 23.25 (-0.62), GXP: 28.09 (+0.35), EAC: 8.13 (+0.02), DXCM: 54.94 (+0.99), CSC: 64.36 (+0.24), AEL: 28.73 (+0.12), HNSN: 0.55 (-0.02), CFN: 59.18 (+0.04), ANAC: 30.58 (+0.16), DAR: 18.35 (-0.06), GST: 2.47 (-0.03), ARC: 9.80 (+0.12), FIVN: 4.56 (+0.11), ELON: 1.72 (+0.03), FSLR: 43.67 (-0.39), EZPW: 11.48 (-0.20), ALIM: 5.43 (-0.06), FWM: 2.80 (-0.03), BRS: 64.93 (+0.02), ECOM: 21.95 (+0.19), FTEK: 3.73 (+0.03), CVT: 27.66 (+0.26), AL: 34.20 (+0.12), BBRG: 12.66 (-0.18), BPZ: 0.25 (+0.03), ECPG: 43.81 (-0.11), HTGC: 15.13 (+0.39), AIRM: 43.03 (-0.10), BNFT: 32.78 (+0.75), ENOC: 15.37 (+0.03), HPTX: 21.91 (-0.08), AGO: 26.28 (+0.23), FICO: 72.85 (+0.40), FF: 13.09 (+0.23), FI: 16.80 (-0.22), EVC: 6.59 (+0.09), EBS: 27.64 (+1.28), ABCO: 49.30 (-0.58), DIOD: 27.55 (+0.29), DIS: 94.42 (-0.27), EGOV: 18.66 (+0.19), APEI: 36.33 (+0.24), DVA: 76.06 (+0.07), CLVS: 54.58 (+0.43), HCI: 45.48 (-0.09), BRKR: 19.50 (+0.09), HGR: 23.20 (+0.12)
Hansen Medical Announces 2014 Release of Third Quarter Earnings Results
Marketwired - Tue Nov 04, 7:30AM CST
Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, today announced it will release its financial and operating results for the third quarter ended September 30, 2014, after market close on Thursday, November 6, 2014.
HNSN: 0.55 (-0.02)
Hansen Medical Receives CE Mark for Magellan(TM) 6Fr Robotic Catheter
Marketwired - Mon Nov 03, 3:09PM CST
Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, today announced the Company's Magellan(TM) 6Fr Robotic Catheter has received European Conformity (CE) Marking for use in the peripheral vasculature. Achieving this milestone allows the Company to market the Magellan 6Fr Robotic Catheter in Europe and other countries that require the CE Mark.
HNSN: 0.55 (-0.02)
Hansen Medical Announces Global Launch of the Sensei X2(R) Robotic System
Marketwired - Thu Oct 30, 7:30AM CDT
Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, today announced the Sensei X2 Robotic System is commercially available in the U.S. and European Union. Sensei X2 is a technological leap forward; featuring faster processing speeds, enhanced image integration, and a lower profile design. Launch of Sensei X2 is a key milestone as Hansen continues to deliver on its pipeline of innovative robotic platforms for electrophysiology procedures.
HNSN: 0.55 (-0.02)
Computer Assisted Surgical (CAS) Systems - 2014 Global Strategic Business Report
M2 - Tue Oct 28, 4:16AM CDT
Research and Markets (http://www.researchandmarkets.com/research/46xq77/computer_assisted) has announced the addition of the "Computer Assisted Surgical (CAS) Systems - Global Strategic Business Report" report to their offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. This report analyzes the worldwide markets for Computer Assisted Surgical (CAS) Systems in US$ by the following Product Segments: - Surgical Planners and Simulators - Surgical Navigation Systems - Surgical Robots The report profiles 56 companies including many key and niche players such as: - 3D Systems Corporation - Accuray, Inc. - B. Braun Melsungen AG - Brainlab AG - CAE, Inc. - CONMED Corporation - Curexo Technology Corporation - Hansen Medical, Inc. - Intuitive Surgical, Inc. - Medtronic, Inc. - Mazor Robotics Ltd. - Northern Digital Inc. - Polhemus, Inc. - Simbionix USA Corp. - Stryker Corporation Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Industry Overview 2. Surgical Robots Market - A Review 3. An Insight Into Surgical Planners & Simulators Market 4. Surgical Navigation Systems Market 5. Product Overview 6. Cas In Select Medical Domains 7. Product Introductions/Innovations/ Approvals 8. Recent Industry Activity 9. Focus On Select Players 10. Global Market Perspective III. Market 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. Rest Of World IV. Competitive Landscape Total Companies Profiled: 56 (including Divisions/Subsidiaries - 57) - The United States (38) - Canada (3) - Japan (1) - Europe (14) - - France (1) - - Germany (6) - - The United Kingdom (2) - - Italy (1) - - Rest of Europe (4) - Middle East (1) For more information visit http://www.researchandmarkets.com/research/46...r_assisted
ISRG: 530.94 (+4.78), MDT: 74.08 (+0.31), HNSN: 0.55 (-0.02), DDD: 30.54 (-0.64), CNMD: 45.33 (+0.42), MZOR: 13.01 (-0.68), ARAY: 7.54 (+0.19), SYK: 96.00 (-0.61)
FDA clears St. Jude ablation catheter
Seeking Alpha - at Seeking Alpha - Mon Oct 27, 10:41AM CDT
BSX: 13.13 (+0.07), ABT: 45.70 (-0.02), JNJ: 104.59 (+0.31), BCR: 169.10 (-0.44), MDT: 74.08 (+0.31), HNSN: 0.55 (-0.02), STJ: 66.67 (+0.67)
Hansen Medical Announces Completion of First Robot-Assisted Uterine Fibroid Embolization Procedure in United States
Marketwired - Tue Oct 21, 7:32AM CDT
Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, today announced the completion of the first robot-assisted Uterine Fibroid Embolization (UFE) in the United States. Sandeep Rao, MD, Interventional Radiologist, performed the procedure at Sierra Medical Center in El Paso, Texas using the Magellan Robotic System.
HNSN: 0.55 (-0.02)
Hansen Medical Appoints Brian Sheahan as Vice President of Clinical, Regulatory and Quality Affairs
Marketwired - Mon Oct 20, 3:05PM CDT
Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, today announced it has named Brian Sheahan as Vice President of Clinical, Regulatory and Quality Affairs. Mr. Sheahan will report directly to Hansen's President and Chief Executive Officer, Cary Vance.
HNSN: 0.55 (-0.02)
Volcano Corp Banks on IVUS Portfolio amid Several Odds - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Oct 13, 1:30PM CDT
On Oct 10, we issued an updated research report on leading precision guided therapy tools provider, Volcano Corporation (VOLC).
BONE: 2.59 (-0.02), HNSN: 0.55 (-0.02), VOLC: 17.95 (+0.02), EW: 130.75 (+1.17)